Affordable Radical Prostatectomy to Beat Prostate Cancer in India

Why India for Radical Prostatectomy?

Like other branches of medicines, Urology is also considered to be one of the most competitive areas for surgeons in India. By virtue of highly qualified and skilled urologists, India has made a significant contribution in alleviating the miseries of patients with eradication of urological diseases.

The 21st century has brought revolution in field of hospital infrastructure that marked the beginning of most modern hospitals that provided state-of-the-art medical facilities and surgical care in all aspects of urology.

When it comes to Radical Prostatectomy, hospitals in India are now well equipped with latest instruments and technology for treating prostate cancer routine through:

• Traditional Approach  i.e. Open prostatectomy in which a large incision is given
• Minimally Invasive Approach – Performed through small incisions

Minimally invasive surgery for radical prostatectomy in India is performed in two different procedures i.e.

• Laparoscopic Prostatectomy
• Robot-Assisted Prostatectomy
• Laser Prostatectomy

India is an ideal destination for Radical Prostatectomy not only for skillful surgeons, ultra modern techniques and world-class hospitals but for most cost effective radical prostatectomy in India as well.

Success rate of Radical Prostatectomy in India

The success of radical prostatectomy in India depends upon spread of cancer. If prostate cancer is limited to the prostate, success rate of Radical Prostatectomy is quite high. Patients in whom prostate cancer has not spread, after radical prostatectomy in India, there are about 80-85% chances of survival for 10 years or more can be there.

However, men in whom prostate cancer has spread further treatments like Radiation Therapy and Hormone therapy may also be required in conjunction with Radical Prostatectomy.

Who are Best Radical Prostatectomy Doctors in India?

In fact, there is no dearth of efficient Uro-Surgeons for radical prostatectomy in India yet some of the best Radical Prostatectomy doctors in India are:

• Dr. Sanjay Gogoi, Fortis Hospital, New Delhi 
• Dr. (Col.) Rajeev Sood, Fortis Hospital, New Delhi
• Dr. Kapil Kumar, BLK  Super Specialty Hospital, New Delhi
• Dr. Sameer Kaul, Indraprastha Apollo, New Delhi 
• Dr. Prof. P.B. Sivaraman, Fortis Malar, Chennai
• Dr. Yuvaraja T.B, Kokilaben Dhirubhai Ambani Hospital, Mumbai
• Dr. Yogesh Kulkarni, Kokilaben Dhirubhai Ambani Hospital, Mumbai
• Dr. Paras Singhal, Dharamshila Narayana Hospital, New Delhi 
• Dr. Rajeev Agarwal, Medanta – The Medicity, Gurgaon
• Dr. Biswajyoti Hazarika, Artemis Hospital, Gurgaon 

What is Cost of Radical Prostatectomy Surgery in India?

Cost of radical prostatectomy in India depends upon various factors, such as:

• Stage of prostate cancer
• Condition of Patient
• Surgical procedure – Open, Laparoscopic or Robotic Radical Prostatectomy
• Qualification, expertise and reputation of surgeon
• Type of Hospital – Government, Charitable or Private
• Any other concurrent treatment in conjunction with Radical Prostatectomy 
• Room Category
• Diagnostic and other nursing facilities availed

However, despite most skilled Radical Prostatectomy, the cost of radical prostatectomy in India is far too less than what it costs in western or developed countries.

Why Ghana Patients choose Radical Prostatectomy Surgery in India?

For Radical Prostatectomy Ghana patients choose India due to:

• Highly qualified and experienced surgeons of International repute
• World-class hospitals equipped with latest technology
• Use of latest surgical procedures
• Impeccable pre and post operative care by doctors and nursing staff
• Priority appointment
• No waiting list
• Easy access of surgeons 
• Ease of obtaining visa 
• World-class hotel and travel arrangements
• No language problem

Above all Ghana patients will have to pay just one fifth of what they would pay in developed countries for similar surgical procedure. In addition, they can experience and enjoy traditional Indian hospitality and culture. 

Get Fast Track Appointment with Best Radical Prostatectomy Doctor in India - Click Here

Read More

Can a Knee Replacement Last a Lifetime?

Any other field of medicine, there are advancements in the field of hip and knee transplant surgery. This is a requirement of the present time to develop technology by which the replaced joints last for a longer period especially when many patients are coming for joint replacement at a younger age.

Robotic surgery, cementless implant among advances that could lead to longer-lasting knee replacement surgery. 

The first advancement is that there is increasing use of the robotic-assisted system in  Knee and hip transplant. The extreme accuracy provided by the robotic-assisted system could potentially improve the longevity of a knee or hip replacement. This is an important consideration, especially for younger patients; says Dr Westrich. & Studies have shown that optimal alignment and positioning of the implant are critical for the long term success of a joint replacement.

Another major advance is a cementless knee replacement in which cement is no longer needed to attach the implant to the bone.

“This, we feel, may also lead to a joint replacement that lasts longer and may not require revision surgery in the future,” Dr Westrich said. “The cementless knee replacement, which is FDA-approved for use with a robotic system, combines two of the most recent knee replacement advancements into one high tech procedure that aims to benefit patients.”

The length of time a joint replacement will last is an important consideration, especially for younger patients in their 40s or 50. The standard knee implant used in joint replacement usually lasts a long time – generally 15 to 20 years – but it doesn’t last indefinitely. When the implant wears out or loosens, patients generally need a second knee replacement, known as revision surgery. Dr Westrich believes the cementless knee replacement implanted with robotic-assisted surgery could change that. “The combination of these two major technological advances has dramatically changed the way I do knee replacements,” said Dr Westrich.

Statistics show that increasing numbers of younger people are having a joint replacement because they don’t want arthritic pain to slow them down. Once they have a knee replacement, these active patients generally put more demands on their joint, causing more wear and tear, according to Dr Westrich. With a conventional cemented prosthesis, chances are they’ll need another surgery down the road. This often has to do with the loosening of the implant from the bone, much like a cemented crown on a tooth

In a standard knee replacement, the components of the implant are secured in the joint using bone cement. It’s a tried and true technique that has worked well for decades. But eventually, over time, the cement starts to loosen from the bone and/or the prosthesis. “With the new cementless prosthesis, the components are press-fit into place for ‘biologic fixation,’ which basically means that the bone will grow into the implant,” Dr Westrich explains. “In addition, more accurate positioning of the implant is critical, and robotic-guidance allows for pinpoint accuracy.”

With biologic fixation, many joint replacement specialists believe that loosening over time could be less likely. “A total knee replacement could potentially last much longer, even for a patient’s lifetime,” Dr Westrich says.

“Cementless implants have been used in total hip replacement surgery for many years and essentially replaced cemented implants for the same reason. Because of the knee’s particular anatomy, it has been much more challenging to develop a cementless prosthesis that would work well in the knee,” he explains. “Now I believe the time has come. Major advances in design, technology and biomaterials have paved the way for a viable cementless knee implant.”

Candidates for the cementless procedure are generally patients under 70 with good bone quality to promote biological fixation. In addition to younger patients, the cementless implant may also prove to be a good option for patients with excess weight who tend to put more stress on their joint replacement, sometimes causing the cement to loosen prematurely. Studies are underway to see how patients with cementless knee replacements do over the long term.

Source

Read More

15 Year Old From Iraq Received Cornea Transplant Of Stillborn Infant India

As a boy growing up in his hometown Iraq, Ammar Ebeid suffered from vision problems due to keratoconus at the tender age of 15. He received a cornea transplant in India from a stillborn infant, which restored his eyesight. Here is his journey of cornea transplant experience in India.

Ammar Ebeid was born with compromised vision because of a scarred cornea, an injury that prevents light from passing through the pupil. As he grew, his eyesight got worsened until his vision was less than 20%. In spite of undergoing several treatments like sodium-based eye dropped, blurry image, and did not make any improvement through the day. Ammar from Iraq did not get any relief, as he was suffering from his eye surgery since a very long time.

After being blind all his life, Ammar could now see the world around him due to the generosity of his cornea donor and skilled medical team. Back in Iraq, after visiting the doctor, he was being told due to the cornea injury, “I would need to undergo corneal transplant the procedure would replace his damaged cornea with a healthy one from a donor.” Following my research about the procedure, I started looking out the best hospital for cornea transplants all over the world. That’s when Tour2india4health consultant helped me out in getting in touch with the top hospital and the best surgeon. I was appointed case manager who advised that I should get the procedure done at Medanta Hospital in Delhi as it is considered among the best eye hospital in India and very were absolutely right about it. My decision to esquire on their website regarding my medical condition was the right thing, as they guided me to the right path.

After making a final decision to visit India, my visa was arranged by the case manager of Tour2india4health consultant by arranging a visa invitation letter from Medanta Hospital Delhi. Apart from giving me information, all the other necessary arrangements were made including hotel booking as per my preference.  I was picked and dropped from the airport also by a team member. They made my trip to India very smooth with all top faculties arranged pre hand.

After reaching India for the procedure, out the wait was not long. As the same evening after the initial appointment in the morning, we were called back to the hospital as they have found a donor in a stillborn child, whose parents were ready to donate his cornea. The surgery was performed the very next day by a team of skilled ophthalmologists who are considered best doctors in India. My surgery was a great success; my cornea transplant in India made my eyesight much better as tearing effects had stopped and my vision started to improve drastically. No irritation anymore and I am very pleased with the results. 

Medanta Hospital Delhi in the best destination for eye treatments and is considered as the top cornea transplant hospital in India. As the hospital has all the latest facilities and equipment required for such an advanced diagnosis and highly delicate treatment. I am thankful to the surgeon for making me a stress-free life which was i was going since my birth. My new cornea is not light sensitive and without any pain. I am able to stay late nights without suffering from the swollen and painful eye. My life no longer revolves around troubles with my eye condition.

Tour2india4health consultant team has been a great support through my entire treatment and trip to India. They are providing me with the best cornea transplant hospital and surgeon in India, offering low-cost treatment and guided me throughout my stay and even in a visa application. A team member was always in touch with me, I never had to worry about anything, Inspite vesting to an unknown country. I was constantly helped and I am extremely thankful to them.”

Thanking You
Ammar Ebeid(Iraq)

Read More

India’s Youngest Successful Liver Transplantation on a One-Month-Old Baby, Performed at Dr Rela Institute & Medical Centre

Dr. Rela Institute & Medical Centre performed India’s first successful liver transplantation on a one-month-old baby on 23rd July in the city. The youngest child to undergo liver transplantation in the country is now doing well and is under the hospital’s postoperative care.

This rare surgery was performed on Aadav (name changed) from Mumbai, who had developed vomiting in the first week of birth, requiring immediate hospitalization. What was believed to be a simple infection, was later diagnosed as urea cycle disorder, which is a metabolic disorder.

When the parents realized that liver transplantation was the only curative treatment option, they shifted the child from Mumbai to Dr. Rela Institute & Medical Centre. The 10-hour long surgery was performed by an expert team of pediatric transplant surgeons and pediatric anesthetists.

Commenting on the first of its kind surgery, Prof Mohamed Rela, Chairman and Managing Director of Dr Rela Institute & Medical Centre, said, “I am glad that a quick diagnosis and timely supportive measures were initiated in mumbai that has prevented the child from having brain damage. The parents took the right decision to let their baby undergo liver transplantation. No centre in India has so far performed liver transplantation on such a young infant.

He added that though metabolic disorders are rare, they are important causes of liver diseases and liver failures in newborns. However, liver transplantation can save them effectively. Though technically difficult neither the weight, nor the age of the baby is a limiting factor.

Talking about the disorder, Dr Naresh Shanmugam, Paediatric Hepatologist and Director for Women & Child Health Department at Dr Rela Institute & Medical Centre, said, “Urea cycle disorder results in high ammonia levels in the blood. The condition refers to the inability of the liver to convert ammonia, which is produced as a byproduct while the body metabolis es proteins, into urea. As the presence of ammonia in the blood increases, it causes swelling in the brain resulting in coma and even death. Immediate action includes stopping protein intake and do dialysis to remove the ammonia. But liver transplantation is the permanent solution.

He added that on average one in 3000 children are born with some form of metabolic disorders in the world. The metabolic disorders can be effectively detected by what is known as the heel prick test, which requires only one drop of blood.

Dr. Ilankumaran Kaliamoorthy, Chairman, Medical Advisory Board at Dr Rela Institute & Medical Centre, said, “Performing liver transplantation in newborn & underweight babies is very challenging. At Dr. Rela Institute, we believe that with our expertise, world-class facilities & infrastructure, age is no barrier for liver transplantation. We have emerged as the largest liver transplant unit performing liver transplantation for a wide age range from newborns to over 70 years old.

Dr. Rela Institute & Medical Centre have the expertise and well-equipped paediatric and newborn intensive care unit to perform complex liver, bone marrow, kidney and intestinal transplant surgeries on babies successfully.

About Dr. Rela Institute & Medical Centre:

Dr. Rela Institute & Medical Centre (RIMC), an International Medical facility, is a quaternary care hospital dedicated to fostering and responding to the needs of a diverse patient population. The hospital provides high quality healthcare with state-of the art infrastructure facilities and experienced, caring medical professionals.

RIMC is designed to provide multi-speciality care with special focus on multi-organ transplantation and critically ill patients. In addition to quaternary care in all specialties, the hospital is committed to providing day-to- day “primary and secondary care” to patients. RIMC has one of the world’s largest dedicated liver intensive care units.

RIMC is a multi-super specialty hospital in a sprawling landscape of 36 acres located in Chromepet, Chennai, Tamilnadu, India.

• The facility, with 450 beds inclusive of 130 critical-care beds, 14 operating rooms and sophisticated reference laboratories and radiology services, is conveniently located close to road, rail and air transport.
• RIMC is led and managed by world-renowned doctors who are committed to healthcare.
• RIMC offers a wide spectrum of clinical care, education and research.
• RIMC is driven by patient needs, comfort and trust.

Source

Read More

24-Year old Mumbai student undergoes Heart and Lung Transplant at Global Hospital to conquer a rare and complex Congenital Heart Disease

Mumbai : A 24 year old Mumbai girl who was suffering from a rare and complex congenital heart disease underwent a combined heart and lung transplant at Global Hospital, Mumbai. Akshara a resident of Panvel, Mumbai suffered from ventricular septal defect since childhood and this defect over the years led to Eisenmenger’s syndrome. Although she was managed medically for a very long time, her condition worsened off late, and she had to be put on home-based oxygen therapy. The 24-year-old underwent a combined heart and lung transplant in the month of June 2019 and is recovering well.

The burden of patients with inoperable adult congenital heart disease and secondary pulmonary hypertension in this country is overwhelming. These individuals have a condition called Eisenmengers syndrome. Many of them continue to turn deeply blue over time and develop secondary complications like cerebral strokes, severe right heart failure, infective endocarditis and die painful deaths after suffering immeasurably.

Dr Sandeep Attawar, Director and Chair of the Heart & Lung Program, Gleneagles Global Hospitals said,“The individuals who have Eisenmengers syndrome could have undergone corrective heart surgery in their infancy or childhood that would have prevented this fate. However, it is only of recent that these facilities have been more common place in this country. So, these individuals that missed the bus, now are condemned to a pathetic existence unless an option such as the replacement of these seriously damaged organs is considered or feasible.”

“However, for the replacement of the seriously damaged organs, there has to be an increase in deceased organ donation,” stated Dr Sandeep.

He also mentioned that there is an uptick in awareness on organ donation and a ray of hope for individuals with this advanced and medically untreatable heart disease.

“The final solution for Eisenmengers syndrome is a heart and double lung transplantation. Akshara is one such young girl who had ventricular septal defect that wasn’t operated upon in her childhood. Heart-lung transplantation is the simultaneous surgical replacement of the heart and lungs in patients having end-stage cardiac and pulmonary disease. It is a viable treatment option,” mentioned Dr Attawar.

Patients who are chosen for the heart and lung transplantation are selected carefully after a series of coordinated and properly sequenced steps. As per  The International Society for Heart and Lung Transplantation, the indications for heart and lung transplant are congenital heart disease with Eisenmenger syndrome followed by idiopathic primary pulmonary hypertension with terminal right heart failure and cystic fibrosis with severe right heart dysfunction.

Akshara’s transplant lasted for 6 –7 hours. Post-surgery she was rehabilitated and was subsequently discharged in mid-July. She has been regularly following up with the clinical team and is recuperating well. Her follow up lung biopsies and levels of immunosuppressive medications are being monitored closely and treated under close medical supervision.

Patient Akshara Aher says,  ” I am thankful to Global Hospital transplant team who have helped me to pursue my dream as a pharmacist & follow her hobby to dance and mountain climbing in her second phase of life.

Dr Vivek Talaulikar, Chief Executive Officer, Global Hospital said, “I would like to thank our doctor teams for their tremendous efforts that they have put in to give Akshara a new lease of life. Till date, Global Hospital, Mumbai, has successfully carried out three bilateral lung transplants, and 1 combined heart and bilateral lung transplant. Our program will offer a safe and caring atmosphere for all patients like all our other organ transplant programs running for decades across India.”

“I would specially thank the donor family who have taken up a brave cause of donating the organs of their loved ones. Today as you see, organ donation has given a new life for this youngster. I would appeal to the communities via the media to come forward and pledge for organ donation,” added Dr Vivek.

Source

Read More

Robotic surgery beneficial for urology patients [Sponsored content]

source - www.newbernsj.com

Urology-related robotic surgery is a huge benefit to patients who previously would have had to undergo open surgery with its long incisions and long hospital stays, said Dr. Hoyt B. Doak IV of CarolinaEast Urology in New Bern.

“For us that’s a really big deal, to be able to avoid a big open incision,” said Doak, who has been doing robotic surgeries for seven years, with five of those years at CarolinaEast Medical Center.

While surgeons in other specialties could be doing some surgeries robotically, laparoscopically or open, those in urology essentially have only two choices – robotic or open, he said.

“The cases that we do in urology are cases that are mostly just too technically difficult to be done laparoscopically,” Doak said. “They require sewing and fairly complex reconstruction that requires suturing. It is very difficult laparoscopically unless you’re a highly experienced laparoscopic surgeon that doesn’t really do anything else.”

In urology robotic surgery is compared to open surgery for most cases and certainly for the robotic prostatectomy and partial nephrectomy – surgeries for cancer of the prostate and kidney, he said.

The prostatectomy involves removing the prostate, a walnut-sized organ that sits in the very bottom of the pelvis.

“It’s a really very tight space,” Doak said.

If the prostatectomy is done with open surgery, it requires a 4- to 5-inch incision.

About prostate cancer

Other than skin cancer, prostate cancer is the most common cancer in American men. The American Cancer Society’s estimates for prostate cancer in the United States for 2019 are:

• About 174,650 new cases of prostate cancer.

• About 31,620 deaths from prostate cancer.

Risk of prostate cancer

About 1 man in 9 will be diagnosed with prostate cancer during his lifetime.

Prostate cancer develops mainly in older men and in African-American men. About 6 cases in 10 are diagnosed in men age 65 or older, and it is rare before age 40. The average age at the time of diagnosis is about 66.

Deaths from prostate cancer

Prostate cancer is the second leading cause of cancer death in American men, behind lung cancer. About 1 man in 41 will die of prostate cancer.

Prostate cancer can be a serious disease, but most men diagnosed with prostate cancer do not die from it. In fact, more than 2.9 million men in the United States who have been diagnosed with prostate cancer at some point are still alive today.

Source: American Cancer Society

“Visibility down in that space when you’re doing an open prostatectomy is very poor,” he said. “A lot of the surgery has to be done by feel just because you can’t see down there because there’s too much stuff in the way.”

When a prostatectomy is done robotically, a camera is put in through a tiny incision at the belly button, with instruments inserted in similar incisions on either side.

“We can take that camera all the way deep down in the pelvis and see exactly what’s going on down there,” Doak said. “Visibility is excellent. We can see right where the nerves and the blood vessels are that are responsible for potency, for sexual function. We can see the urethra and the bladder. It allows for really good visualization of what’s going on.”

From the patient’s standpoint, he said, the recovery is shorter, the pain is less, the blood loss is less and there is a lower stricture rate.

“In terms of other things that patients care about like erectile dysfunction, urinary continence and that kind of thing, the robot has never been proven to be superior to open surgery,” Doak said.

But a robotic prostatectomy does offer the benefits of minimally invasive surgery.

“Our patients go home the next day instead of spending two or three nights in the hospital and they require very little pain medicine,” he said. “Many of my patients will go home and not require any narcotic pain medicine. They’ll just go home on Tylenol or ibuprofen. I don’t send them home without narcotic pain medicine, but a lot of times they will come back and tell me they didn’t need it at all, or they only took two pills.”

For the kidney cancer surgeries such as the partial nephrectomy, the open alternative is extremely morbid, requiring a large, painful incision, Doak said.

“Those patients used to stay in the hospital for a long time – three, four or five days,” he said. “They used to have to have an epidural for pain control for several days and would get tons of narcotics for pain. It was a really tough surgery to have.”

The benefit of the partial nephrectomy is that it allows the surgeon to remove the part of the kidney that has cancer and leave the rest of the kidney in place.

“A robotic partial nephrectomy allows us to do that with much less morbidity than we used to have to inflict on people,” Doak said. “They have great outcomes. They are able to retain their kidney and they are able to go home sometimes the next day or sometimes after two nights. They are up on their feet, usually, the same night as surgery. It is like night and day from having a big open surgery.”

source

Read More

New Stem Cell Therapy Can Treat Rare Blood Disorders

SOURCE - valuewalk.com

It’s extremely difficult to treat rare health disorders which can be fatal. However a new, private biotech project aims to change that, after combining CRISPR, a gene-editing tool which is bacteria-derived, and stem cell therapy. Now, this new stem cell therapy will treat the first human patient suffering from a rare blood disorder.

Vertex Pharmaceuticals and CRISPR Therapeutics announced that they are treating a patient who suffers from beta thalassemia, using the new stem cell therapy. The therapy is using CRISPR/Cas9 hematopoietic stem cell therapy, also called CTX001.

According to the press release, the new technique is still in clinical research, but it’s ready enough to treat human patients, yielding good results so far. Using this approach, researchers also want to learn whether they’ll be able to use the same approach to cure sickle cell disease. The clinical study with a human patient will be conducted in the U.S. in mid-2019.

“We have made tremendous progress with CTX001 and are pleased to announce that we’ve treated the first patient with beta thalassemia in this clinical study,” Dr Samarth Kulkarni, Chief Executive Officer of CRISPR Therapeutics, said in the press release. “Treating the first patient in this study marks an important scientific and medical milestone and the beginning of our efforts to fully realize the promise of CRISPR/Cas9 therapies as a new class of potentially transformative medicines to treat serious diseases.”

Scientists need to learn more about the rare blood disorders to be able to treat them efficiently. Beta thalassemia is a blood disorder which is inherited through genetics. People who suffer from this disorder are not able to form enough hemoglobin in their body, which is a protein inside red blood cells and is used for carrying oxygen through the body in the breathing process. Lack of hemoglobin is responsible for many conditions like anemia, shortage of breath and fatigue.

The new stem cell therapy would see researchers take a patient’s hematopoietic stem cells through blood samples and change them by using the CRISPR/Cas9 technology. This would make higher levels of fetal hemoglobin to be produced in the red blood cells.

Fetal hemoglobin is a special kind of hemoglobin which is present in the human body when we are born. However, as a person grows up, it is replaced by an adult form of hemoglobin.

The treated blood cells would then be reinfused back into the bloodstream, with the ability to produce fetal hemoglobin which would hold more oxygen.

“Beta thalassemia and sickle cell disease are serious, life-threatening diseases, and we are evaluating ex vivo treatment with CTX001 with the goal of creating a one-time potential curative therapy,” added Dr David Altshuler, Executive Vice President and Chief Scientific Officer at Vertex. “Our collaboration with CRISPR Therapeutics offers an exciting new potential therapeutic approach that complements our strategy of using scientific innovation to create transformative medicines for serious diseases.”

According to the report in Bloomberg, the new therapy has sparked curiosity and attention in the media since Monday, when it was announced, as well as many other biotech companies working in the same field.

Source

Read More

Football: Napoli blow as Spanish defender Albiol undergoes knee surgery

source: www.channelnewsasia.com

MILAN: Napoli's Spanish international defender Raul Albiol has undergone knee surgery in London, the Serie A club said on Tuesday.

"Raul Albiol underwent surgery to clean the patellar tendon of the left knee this morning at the Princess Grace Hospital in London," the club said in a statement.

"The surgery was perfectly successful. In the coming days, the recovery time will be assessed."

Albiol - winner of the 2010 World Cup and two European Championship titles with Spain - could be sidelined for at least a month, according to reports.

The absence of the charismatic 33-year-old who suffers from tendinopathy to the knee is a blow for Napoli who are second in the Italian league this season - 11 points behind champions Juventus.

The club also begins their Europa League campaign against FC Zurich on Thursday, after dropping out of the Champions League.

Albiol joined Napoli in 2013 from Real Madrid where he won La Liga in 2012.

He also won the UEFA Cup trophy with previous club Valencia in 2004.

source

Read More

Cody Undergoes Arthroscopic Knee Surgery

source:www.f4wonline.com

After suffering the injury back in November, Cody Rhodes underwent surgery on his knee this morning.

Cody tweeted after having surgery: "Surgery completed. Went smooth. Back to work. (Cowabunga I guess)"

Brandi Rhodes also wrote before the eraoption was done: "They just took my love @CodyRhodes back for surgery. Hate being on the waiting end this time. But I know he’s going to feel so much better in time for #DoubleOrNothing"

Dave Meltzer reported last month that Cody would be undergoing arthroscopic knee surgery in Atlanta today. Meltzer wrote that the surgery would keep Cody out of action for two to three months, but he isn't scheduled to wrestle until All Elite Wrestling's Double or Nothing event on May 25.

Cody suffered the injury when teasing throwing a T-shirt into the crowd at ROH's Global Wars tour show in Buffalo on November 9. An MRI revealed that he had two tears in his meniscus, and Cody opted to wait until after his matches at Final Battle and Wrestle Kingdom 13 until having surgery.

Source

Read More

Stem Cell Therapy Breakthrough Could Help Cure Type 1 Diabetes

MOLEKUUL/SCIENCE PHOTO LIBRARY via Getty Images

Scientists have edged one step closer to a major treatment for (and possibly cure for) type 1 diabetes. A UCSF team has claimed it's the first to turn human stem cells into the mature, insulin-producing cells that type 1 patients don't have. The key was to acknowledge reality in the development of islets, or clusters of healthy beta cells (which generate insulin) in the pancreas. They separated partly differentiated pancreatic stem cells into islets, jumpstarting their development and leading to responses to blood sugar that more closely represented mature cells. Even alpha and delta cells grew more effectively, UCSF said.

The technique has only been tested in mice so far, but the results were positive. It took just a "matter of days" for implanted islets to produce insulin as well as the rodents' native cells.

If the research continues to bear fruit, though, it could offer a much more realistic solution for type 1 diabetes. Pancreas transplants can help, but they frequently fail and still require drugs that suppress your immune system. There are tests for safer and more targeted islet implants, but they still tend to require organs from dead donors. This breakthrough could lead to on-demand implants and make it relatively easy to gain (or regain) healthy insulin levels.

Source

Read More